West Bengal Chemical Industries Limited (WBCIL), a leading name in the global API manufacturing sector, holds 15 patents and has secured a distinguished spot in the Annual Report on Intellectual Property in India 2024-25. 

This government recognition places WBCIL among the country's top innovators, celebrating its contributions to the national patent landscape. 

This dual achievement—being featured in India’s official IP report and securing the coveted MSME Award—cemented the company’s reputation as a research-driven powerhouse in the pharmaceutical industry. 

The inclusion of WBCIL in the Annual Report on Intellectual Property is not just a company milestone; it is a validation of its strategy to prioritize complex chemistry over generic manufacturing. The report highlights organizations that are actively shaping India's status as a global research hub. For WBCIL, this recognition honors a decades-long commitment to developing smarter, safer, and more affordable APIs for pharmaceutical, nutraceuticals and now cosmeceuticals. 

West Bengal Chemical Industries Limited is now the proud patent holder for 15 innovations:

- Improved Ferric Carboxymaltose: A breakthrough process that is cost-effective and designed to reduce side effects

- Ferric Carboxymaltose: A pharmaceutically acceptable composition and preparation

- Iron Isomaltoside: Advanced synthesis for iron therapy

- Iron (III) Coordination Complex: Novel engineering of iron compounds

- Ferric Derisomaltose: High-purity production method

- Ferric Citrate: Pharmaceutical-grade synthesis

- Sucroferric Oxyhydroxide: Critical for kidney disease management

- Enclomiphene Citrate: Specialized synthesis for hormonal therapy

- Ferric Maltol: Preparation of Novel Polymorphic Form ‘s’ of Stabilised Ferric Maltol (Scalable Process)

- Iron (III) Polymaltose Complex: Process for preparation with controlled molecular weight

- Calcium Gluconate: One-Pot Scalable Synthesis (Monohydrate and Anhydrous)

- Ferrous Ascorbate: Innovative "Green Chemistry" preparation

- Liposomal Iron: A novel approach for improved iron supplementation with enhanced stability

- L-Ornithine L-Aspartate: In-situ greener synthetic approach

- Molecules for Anemia Management: (Covering the broader range of iron complexes) 

"Being highlighted in the national IP report is a testament to our scientific team's relentless pursuit of excellence," said WBCIL spokesperson.  

"Our goal has always been to solve real-world healthcare challenges through chemistry. Securing these 15 patents proves that Indian MSMEs can lead the world in high-value innovation," added spokesperson. 

The company is aggressively adopting green chemistry, as seen in its patents for Ferrous Ascorbate and L-Ornithine L-Aspartate. By designing processes that reduce hazardous waste and energy use, WBCIL is setting a new standard for sustainable pharmaceutical manufacturing. 

With 15 patents in hand and national recognition in India’s official IP records, West Bengal Chemical Industries Limited is poised to expand its footprint in regulated markets across Europe, the Americas, and Asia. 

Known for its robust R&D capabilities and high-quality manufacturing standards, WBCIL serves the global pharmaceutical industry with innovative, cost-effective, and sustainable chemical solutions.